Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Rydex Health Care A RYHEX Fund Analysis
Morningstar’s Analysis RYHEX
Will RYHEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar